Topical glycopyrronium tosylate (DRM04) for the treatment of primary axillary hyperhidrosis: Pooled results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials

Topical glycopyrronium tosylate (DRM04) for the treatment of primary axillary hyperhidrosis: Pooled results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials Meeting Abstract

publication date

September 1, 2018

webpage

Web of Science

published in

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY Journal

start page

AB298

end page

AB298

volume

79

issue

3